Pramipexole for the treatment ADHD
    3.
    发明申请
    Pramipexole for the treatment ADHD 审中-公开
    普拉克索治疗ADHD

    公开(公告)号:US20050049289A1

    公开(公告)日:2005-03-03

    申请号:US10958156

    申请日:2004-10-04

    IPC分类号: A61K31/425 A61K31/428

    摘要: A method for prevention and/or treatment of ADHD in a patient in need thereof, the method comprising administering to the patient an effective amount of 2-amino-4,5,6,7-tetrahydro-6-n-propylaminobenzothiazole or a pharmacologically acceptable acid addition salt, hydrate, or solvate thereof

    摘要翻译: 一种在有需要的患者中预防和/或治疗ADHD的方法,所述方法包括向患者施用有效量的2-氨基-4,5,6,7-四氢-6-正丙氨基苯并噻唑或药理学上 可接受的酸加成盐,水合物或溶剂合物

    Method of Using Flibanserin for Neuroprotection
    8.
    发明申请
    Method of Using Flibanserin for Neuroprotection 审中-公开
    氟班色林用于神经保护的方法

    公开(公告)号:US20120035185A1

    公开(公告)日:2012-02-09

    申请号:US13276970

    申请日:2011-10-19

    申请人: Franco Borsini

    发明人: Franco Borsini

    IPC分类号: A61K31/496 A61P25/00

    摘要: The present invention relates to the use of 1-[2-(4-(3-trifluoromethyl-phenyl)piperazin-1-yl)ethyl]-2,3-dihydro-1H-benzimidazol-2-one, optionally in the form of its pharmaceutically acceptable acid addition salts and optionally in the form of its hydrates or solvates, for preparing a pharmaceutical composition with a neuroprotective activity.

    摘要翻译: 本发明涉及1- [2-(4-(3-三氟甲基 - 苯基)哌嗪-1-基)乙基] -2,3-二氢-1H-苯并咪唑-2-酮的用途, 的药学上可接受的酸加成盐,并且任选地以其水合物或溶剂化物的形式,用于制备具有神经保护活性的药物组合物。